Home / Articles / Identification of one more metabolite from the Siberian bioluminescent earthworm Henlea sp.

Identification of one more metabolite from the Siberian bioluminescent earthworm Henlea sp.

R. I. Zagitova 1, 2, 
R. I. Zagitova
V. N. Petushkov 3, 
V. N. Petushkov
N. S. Rodionova 3, 
N. S. Rodionova
M. V. Vavilov 1, 2, 
M. V. Vavilov
O. A. Belozerova 1, 
O. A. Belozerova
M. A. Dubinnyi 1, 
M. A. Dubinnyi
I. V. Yampolsky 1, 4
I. V. Yampolsky
1 M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russian Federation
3 Institute of Biophysics, Siberian Branch of the Russian Academy of Sciences, 660036 Krasnoyarsk, Russian Federation
Published 8 October 2026 , received 2 June 2026
Communication
0
Cite this
GOST
 | 
Cite this
GOST
Khokhlova A. N. et al. Identification of one more metabolite from the Siberian bioluminescent earthworm Henlea sp. // Mendeleev Communications. 2026.
GOST all authors (up to 50)
Khokhlova A. N., Zagitova R. I., Petushkov V. N., Rodionova N. S., Vavilov M. V., Belozerova O. A., Dubinnyi M. A., Yampolsky I. V. Identification of one more metabolite from the Siberian bioluminescent earthworm Henlea sp. // Mendeleev Communications. 2026.
RIS
 | 
Cite this
RIS
TY - JOUR
DO - 10.71267/mencom.8105
UR - https://mendcomm.colab.ws/publications/10.71267/mencom.8105
TI - Identification of one more metabolite from the Siberian bioluminescent earthworm Henlea sp.
T2 - Mendeleev Communications
AU - Khokhlova, A. N.
AU - Zagitova, R. I.
AU - Petushkov, V. N.
AU - Rodionova, N. S.
AU - Vavilov, M. V.
AU - Belozerova, O. A.
AU - Dubinnyi, M. A.
AU - Yampolsky, I. V.
PY - 2026
DA - 2026/10/08
PB - Mendeleev Communications
ER -
BibTex
Cite this
BibTex (up to 50 authors)
@article{2026_Khokhlova,
author = {A. N. Khokhlova and R. I. Zagitova and V. N. Petushkov and N. S. Rodionova and M. V. Vavilov and O. A. Belozerova and M. A. Dubinnyi and I. V. Yampolsky},
title = {Identification of one more metabolite from the Siberian bioluminescent earthworm Henlea sp.},
journal = {Mendeleev Communications},
year = {2026},
publisher = {Mendeleev Communications},
month = {Oct},
url = {https://mendcomm.colab.ws/publications/10.71267/mencom.8105},
doi = {10.71267/mencom.8105}
}
Views / Downloads
38 / 18

Abstract

Tryptophan-2'-carboxylate derivative possessing pyrido[3,4-b]indole core was discovered in the unique bioluminescent system of the Henlea earthworms, and its structure was confirmed by the independent synthesis. The synthetic compound exhibits the characteristic 300 nm absorption and can be proposed as a candidate for oxyluciferin or a related oxidized luciferin product.

Keywords

Henlea earthworm
bioluminescence
mass-spectrometry
metabolite
natural products
pyrido[3,4-b]indole
tryptophan

Communication

The study of the bioluminescent (BL) system of Henlea earthworms began in 2002 with the discovery of two new luminescent species, H. petushkovi and H. rodionovae, in the Krasnoyarsk and Baikal regions of Siberia, Russia.[1] The species were found in small quantities in Siberian taiga together with Fridericia heliota earthworms and in much larger amounts in private gardens.[2] The BL system turned out to be unique, consisting of an approximately 80 kDa luciferase,[1] a low-molecular-weight luciferin (hypothesized to be a tryptophan derivative), calcium ions,[3] oxygen, and a deazaflavin activator.[4] The fluorescence emission spectrum of the deazaflavin activator (ActH) and its structural analog ActS matches the spectrum of the BL reaction (maximum at 464 nm). Moreover, the deazaflavin activator, if present, shifts the BL emission maximum in vitro from violet (approximately 430 nm) to blue (464 nm) by a proposed natural BRET mechanism[5-7] and increases the intensity of the BL signal by a factor of 33.[4]

Earlier, we identified several low-molecular-weight compounds associated with luciferin: tryptophan-2'-carboxylate (T2C) and its derivatives.[5, 8] All T2C compounds exhibit an absorption wavelength maximum at 300 nm (Figure 1); it differs from that of tryptophan (280 nm) due to the presence of a carboxy group at the position 2 of the indole ring. This property allows T2C compounds to be readily identified in the mixture of natural products in the worm extract. The structures of T2C and its N-acetyl derivative were unambiguously established by independent synthesis.[5] Our knowledge about the Henlea BL system is now consistent with the hypothesis that the actual yet unknown oxyluciferin should be among the set of at least eleven T2C derivatives in the Henlea extract.[5] In the present work, we performed the identification of the lowest-mass T2C compound by chemical synthesis and comparison of its chromatographic profile and HRMS spectrum with those of the natural one.

Figure 1
Characterisation of metabolite 1 by chromatography, absorption and fluorescence spectroscopy. (a) HPLC with monitoring at 300 nm. Synthetic compound 1 matches the most hydrophobic peak found in the Henlea extract. (b) Excitation spectra of natural and synthetic 1, emission (fluorescence) spectrum of synthetic 1 (0.1% formic acid, pH 2.88) and bioluminescence (BL) spectrum of Henlea measured without deazaflavin chromophore (16 mM MOPS pH 7 with 1 mmol of CaCl2, data collected with 15 nm intervals, n = 3 experiments are shown[5]). (c) All known T2C compounds. The structures of P300b,c were determined with precision up to the position of the sulfo group and the threonic acid linkage site to T2C.

In our previous study,[5] we reported that chromatographic fractionation of worm extracts yielded fractions containing a chromophore with an absorption maximum at 300 nm (see Figure 1). The ESI-HRMS analysis of the fraction with tR = 5.76 min revealed a molecular ion at [M + H]+ 231.0762, consistent with the molecular formula C12H10N2O3 (calculated [M + H]+ 231.0764),[9] which corresponds to the mass of tryptophan-2'-carboxylate without H2O. The MS2 analysis revealed a key fragment ion at m/z 185.0709, corresponding to the loss of the carboxy group (Figure 2). Based on its retention time in the hydrophobic region of the chromatogram, we hypothesized that the water elimination could occur intramolecularly between the amino group of tryptophan and the carboxy group at the position 2 of the indole ring to give compound 1 comprising pyrido[3,4-b]indole core [see Figure 1(c)]. However, the quantity of the purified natural substance was insufficient for NMR analysis. We hypothesized that its structure did not contain additional stereocenters or other sources of structural ambiguity.

Figure 2
Comparison between tandem mass spectra of the natural and synthetic compounds in positive-ion mode. The parent ion of compound 1 is at m/z 231.0760.

Synthesis of compound 1 from 2-vinylaniline has been reported previously.[10] In this work, we employed a different approach (Scheme 1). Initial compound 2 was prepared according to a previously reported procedure[5] from commercially available Nα-Boc-L-tryptophan using the Pictet–Spengler reaction with formaldehyde.[11] After protection of the amino group,[12] the resulting compound 3 was subjected to oxidation with selenium dioxide[13] to yield aldehyde 4, which was further oxidized with potassium permanganate in aqueous acetone[14] to afford the corresponding carboxylic acid 5. For the cyclization, the Boc protecting group was removed with hydrogen chloride in dioxane[15] to obtain intermediate 6, followed by intramolecular cyclization using O-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU) and diisopropylethylamine (DIPEA) to give product 7.[16] Final hydrogenolysis of the benzyl ester group[17] afforded the target compound 1 in an overall yield of 9% over six steps from reactant 2.

Scheme 1
Reagents and conditions: i, Boc2O, K2CO3, THF/H2O; ii, SeO2, dioxane, reflux; iii, KMnO4, H2O/acetone; iv, HCl/dioxane; v, TBTU, DIPEA, CH2Cl2; vi, H2, Pd/C, MeOH.

The synthesized compound was characterized by HPLC and HRMS. Its retention time coincided with that of the corresponding component from the worm extract (see Figure 1). The MS² fragmentation pattern of synthetic 1 (blue) was identical to that of the natural compound (red) (see Figure 2). These data collectively confirm that we have elucidated the structure of a novel T2C natural product from Henlea. We would postulate that the synthetic sample 1 has (S)-configuration since it was obtained from (S)-tryptophan whereas the synthetic methods employ relatively mild conditions, so the racemizarion if occurs should proceed in small extent. The compound from the earthworm is highly likely (S)-configured being the natural one.

As anticipated, synthetic compound 1 also exhibits an absorption wavelength of 300 nm, even though the carboxy group is replaced by a secondary amide. The emission spectrum was measured at an excitation wavelength of 300 nm and was shown to match the bioluminescence spectrum obtained without the deazaflavin activator, which corresponds to approximately 430 nm [see Figure 1(b)]. This suggests that compound 1 may be the oxyluciferin or a related oxidized luciferin product in the Henlea bioluminescent system. The minor discrepancy observed between the fluorescence and BL spectra can be attributed to the different microenvironments (free vs. enzyme-bound). Final confirmation of this hypothesis can only be achieved after the synthesis of the luciferin. Such work is currently in progress in our group.

To conclude, the synthesis and comparative analysis reliably established the structure of a newly discovered natural T2C derivative from Henlea earthworms. These results may help to elucidate the molecular mechanism of the bioluminescent system in future studies.

This work was supported by the grant of The Russian Science Foundation, Russia, grant no. 24-14-00421, https://rscf.ru/project/24-14-00421/.

Funders

Russian Science Foundation
24-14-00421

References

1.
The Luminescence System of Soil Enchytraeids, Henlea sp., (Annelida: Clitellata: Oligochaeta: Enchytraeidae)
Petushkov V.N., Rodionova N.S., Purtov K.V., Bondar' V.S.
Doklady Biological Sciences , 2002
4.
Deazaflavin cofactor boosts earthworms Henlea bioluminescence
Petushkov V., Vavilov M.V., Ivanov I., Ziganshin R.H., Rodionova N.S., Yampolsky I.V., Tsarkova A.S., Dubinnyi M.A.
Organic and Biomolecular Chemistry , 2023
5.
Henlea earthworm bioluminescence comprises violet-blue BRET from tryptophan 2-carboxylate to deazaflavin cofactor
Petushkov V.N., Vavilov M.V., Khokhlova A.N., Zagitova R.I., Belozerova O.A., Shcheglov A.S., Kovalchuk S.I., Tsarkova A.S., Rodionova N.S., Yampolsky I.V., Dubinnyi M.A.
Biochemical and Biophysical Research Communications , 2024
6.
Energy transfer in a bioluminescent system
Morin J.G., Hastings J.W.
Journal of Cellular Physiology , 1971
7.
Energy Transfer in Bioluminescence
Pi S., Liu Y.
Luminescence , 2026
8.
α‐C‐Mannosyltryptophan is a Structural Analog of the Luciferin from Bioluminescent Siberian Earthworm Henlea sp .
Dubinnyi M.A., Ivanov I.A., Rodionova N.S., Kovalchuk S.I., Kaskova Z.M., Petushkov V.N.
ChemistrySelect , 2020
10.
Direct Tryptophols Synthesis from 2-Vinylanilines and Alkynes via C≡C Triple Bond Cleavage and Dioxygen Activation
11.
Synthesis of 1,2,3,4-tetrahydro-.BETA.-carboline derivatives as hepatoprotective agents. III. Introduction of substituents onto methyl 1,2,3,4-tetrahydro-.BETA.-carboline-2-carbodithioate.
SAIGA Y., IIJIMA I., ISHIDA A., MIYAGISHIMA T., HOMMA K., OH-ISHI T., MATSUMOTO M., MATSUOKA Y.
Chemical and Pharmaceutical Bulletin , 2011
12.
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles
Balazs A.Y., Carbajo R.J., Davies N.L., Dong Y., Hird A.W., Johannes J.W., Lamb M.L., McCoull W., Raubo P., Robb G.R., Packer M.J., Chiarparin E.
Journal of Medicinal Chemistry , 2019
13.
Selenium dioxide oxidation of tetrahydro-β-carboline derivatives
Gatta F., Misiti D.
Journal of Heterocyclic Chemistry , 1987
14.
On‐Surface Synthesis of Cumulene‐Containing Polymers via Two‐Step Dehalogenative Homocoupling of Dibromomethylene‐Functionalized Tribenzoazulene
Urgel J.I., Di Giovannantonio M., Eimre K., Lohr T.G., Liu J., Mishra S., Sun Q., Kinikar A., Widmer R., Stolz S., Bommert M., Berger R., Ruffieux P., Pignedoli C.A., Müllen K., et. al.
Angewandte Chemie - International Edition , 2020
15.
Cyclic phosphoramidates as prodrugs of 2′-C-methylcytidine
Meppen M., Pacini B., Bazzo R., Koch U., Leone J.F., Koeplinger K.A., Rowley M., Altamura S., Di Marco A., Fiore F., Giuliano C., Gonzalez-Paz O., Laufer R., Pucci V., Narjes F., et. al.
European Journal of Medicinal Chemistry , 2009
16.
NEW TRENDS IN PEPTIDE COUPLING REAGENTS
Albeiicio F., Chinchilla R., Dodsworth D.J., Nájera C.
Organic Preparations and Procedures International , 2001
17.
Cyclic dipeptides exhibit potency for scavenging radicals
Furukawa T., Akutagawa T., Funatani H., Uchida T., Hotta Y., Niwa M., Takaya Y.
Bioorganic and Medicinal Chemistry , 2012